These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 703225)

  • 1. [Combined administration of cholinolytic metamizil and L-Dopa in vascular parkinsonism].
    Kamenetskiĭ VK
    Klin Med (Mosk); 1978 Sep; 56(9):113-5. PubMed ID: 703225
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined use of metamizil and midantan in vascular parkinsonism].
    Kamenetskiĭ VK
    Klin Med (Mosk); 1979 Sep; 57(9):59-62. PubMed ID: 491516
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined treatment of parkinsonism with L-dopa and Parkopan].
    Lukasiewicz K
    Wiad Lek; 1977 May; 30(10):775-7. PubMed ID: 867994
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combined treatment of Parkinsonism with L-dopa and peripheral dopa decarboxylase inhibitors--clinical course of 13 cases and levels of serum/dopa and dopamine].
    Mizuno Y; Yoshida M; Obayashi T; Ueki A
    Rinsho Shinkeigaku; 1976 Jul; 16(7):511-9. PubMed ID: 986921
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anticholinergics and levodopa in Parkinson's disease: an unnecessary combination in patients treated for the 1st time].
    Giménez-Roldán S; Mateo D; Gil Núñez A
    Rev Clin Esp; 1980 Dec; 159(6):403-7. PubMed ID: 7221107
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance of pyridoxine administration in L-dopa therapy of Parkinsonism (author's transl)].
    Namba S; Ishimitsu H; Nakasone S
    No To Shinkei; 1980 Oct; 32(10):991-1000. PubMed ID: 6159908
    [No Abstract]   [Full Text] [Related]  

  • 7. [Trans-cerebral electrophoresis of L-DOPA in the complex treatment of parkinsonism].
    Neĭmark EZ; Evtushenko SK; Dukhovnaia MA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1334-8. PubMed ID: 6506979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report on 45-month treatment of parkinsonism with L-dopa, alone and in association with a decarboxilase inhibitor (Ro 4-4602).
    Chouza C; Romero S; Gomensoro JB
    Acta Neurol Latinoam; 1974; 20(1-4):116-38. PubMed ID: 4619960
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current drug treatment of parkinsonism].
    Kistenev BA; Kadykov AS; Pivovarova VM
    Sov Med; 1976 Nov; (11):57-61. PubMed ID: 1006394
    [No Abstract]   [Full Text] [Related]  

  • 10. [Disappearance of the disordered postural regulation of cerebral circulation by the addition of benserazide in parkinsonism treated with L-dopa].
    Boismare F; Samson M; Pouliquen A; Hacpille L
    Therapie; 1976; 31(5):615-22. PubMed ID: 1013953
    [No Abstract]   [Full Text] [Related]  

  • 11. [Improved therapeutic response to L-dopa in Parkinson's disease, when combined with bromocriptine (author's transl)].
    Ulm G
    Nervenarzt; 1981 Feb; 52(2):116-20. PubMed ID: 7219619
    [No Abstract]   [Full Text] [Related]  

  • 12. [Method of treating parkinsonism with metamizil in combination with galanthamine (clinico-experimental basis)].
    Losev NA; Kamenetskiĭ VK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):376-81. PubMed ID: 3993298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experience in treating vascular parkinsonism with metamysil].
    Kamenetskiĭ VK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(3):365-70. PubMed ID: 645311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of the preparation L-dopa in parkinsonism].
    Proniv DI; Sirotina OS; Bukhovtsev PP; Mis'kiv IaI
    Vrach Delo; 1976 Jan; (1):113-6. PubMed ID: 1246837
    [No Abstract]   [Full Text] [Related]  

  • 15. [Combined treatment of Parkinsonism with levopa, midantan and anticholinergic drugs].
    Evtushenko SK
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Dec; 76(12):1797-1802. PubMed ID: 1015115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects and side effects to levodopa in parkinsonism- results of a collaborative study. (5) Combined therapy with a peripheral decarboxylase inhibitor].
    Omoto T
    Rinsho Shinkeigaku; 1976 Dec; 16(12):879-80. PubMed ID: 1035531
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experience using veroshpiron in the combined therapy of parkinsonism].
    Vartanian KZ; Karimova MKh
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(12):14-8. PubMed ID: 3245369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined therapy of parkinsonism with bromocriptine, L-dopa and decarboxylase inhibitor (author's transl)].
    Vardy J; Rabey JM; Streifler M
    Harefuah; 1977 Sep; 93(5-6):129-33. PubMed ID: 924233
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long-term results of L-dopa treatment of parkinsonism].
    Barbeau A
    Union Med Can; 1975 Jan; 104(1):32-8. PubMed ID: 1111195
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of parkinsonism by dopaflex (L-DOPA).
    Grbesa B; Velicković A
    Ther Hung; 1977; 25(3):106-8. PubMed ID: 929475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.